Gabelli Funds LLC trimmed its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 9.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 254,488 shares of the medical device company’s stock after selling 27,777 shares during the […]
Nicholas Company Inc. lifted its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.3% in the fourth quarter, Holdings Channel reports. The firm owned 365,521 shares of the medical device company’s stock after buying an additional 4,855 shares during the period. Nicholas Company Inc.’s holdings in Globus Medical were worth $19,479,000 as of […]
Globus Medical, Inc. (NYSE:GMED – Free Report) – Stock analysts at Zacks Research lifted their Q4 2025 EPS estimates for shares of Globus Medical in a report issued on Tuesday, May 28th. Zacks Research analyst R. Department now expects that the medical device company will post earnings of $0.84 per share for the quarter, up […]
Millrace Asset Group Inc. acquired a new stake in Globus Medical, Inc. (NYSE:GMED – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 39,457 shares of the medical device company’s stock, valued at approximately $2,103,000. Globus Medical accounts for 2.1% […]
Westfield Capital Management Co. LP reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 8.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 594,437 shares of the company’s stock after selling 54,855 shares during the quarter. Westfield Capital Management Co. […]